Clinical Trials Directory

Trials / Unknown

UnknownNCT02838277

Insight Into Subcutaneous Adipose Tissue Disorders

Insight Into Subcutaneous Adipose Tissue Disorders As Part of The TREAT Program (Treatment, Research, Education, Adipose Tissue) at the University of Arizona

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
University of Arizona · Academic / Other
Sex
All
Age
19 Years – 70 Years
Healthy volunteers
Accepted

Summary

The INSIGHT study aims to phenotype individuals with subcutaneous adipose tissue (SAT) disorders specifically lipedema and Dercum's disease with an aim to find a cure for the SAT in these disorders that is resistant to diet and exercise.

Detailed description

Lipedema is a syndrome of painful fatty enlargement of the buttocks, hips and thighs primarily in women which cannot be lost by diet, exercise or bariatric surgery. Arms are affected in 80% of women with lipedema to varying degrees. The etiology of lipedema is not known and there are no evidence-based treatments that work for a majority of individuals except for excision of the subcutaneous adipose tissue (SAT) by liposuction which has risks. Millions of women are affected with lipedema yet they are grossly under-diagnosed, have mobility issues and can develop lymphedema. The goal of this project is to better understand the etiology of lipedema SAT, find out how it is different from non-lipedema SAT, to improve our ability to identify the abnormal SAT and determine the response of the tissue to therapeutics by imaging and biomarkers. People with diffuse Dercum's disease (DD) appear to have lipedema plus a tissue inflammation that causes illness and pain. People with SAT disorders that have similarities to lipedema will also be included in this protocol. More research is needed to determine how these fatty disorders are similar and different from each other and from obesity so they can be distinguished clinically and by laboratory testing and imaging. Since these painful fatty disorders are associated with SAT growth, research focused on these disorders may provide unique insight into mechanisms of obesity.

Conditions

Timeline

Start date
2016-06-01
Primary completion
2018-06-01
Completion
2018-12-01
First posted
2016-07-20
Last updated
2017-09-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02838277. Inclusion in this directory is not an endorsement.